44 related articles for article (PubMed ID: 10598456)
1. [Not Available].
Patol Fiziol Eksp Ter; 1999 Oct; (4):8-16. PubMed ID: 10598456
[TBL] [Abstract][Full Text] [Related]
2. [The positive action of refracterin on the reserve potentials and metabolism of the myocardium during its overload in toxic-allergic myocarditis].
Karsanov NV; Sukoian GV; Dzhibgashvili IK; Tatulashvili DR; Gorelishvili II
Patol Fiziol Eksp Ter; 1999; (4):10-6. PubMed ID: 10636764
[TBL] [Abstract][Full Text] [Related]
3. [The subcellular pathophysiology of heart failure due to toxic-allergic myocarditis and the action of refracterin on intracardiac hemodynamics and the functional state of the 3 subcellular cardiomyocyte systems responsible for the act of contraction-relaxation].
Karsanov NV; Sukoian GV; Dzhibgashvili IK; Tatulashvili DR; Gorelishvili II; Guchua EI
Patol Fiziol Eksp Ter; 1999; (3):3-8. PubMed ID: 10498985
[TBL] [Abstract][Full Text] [Related]
4. [Cardioprotective effect of energostim in toxic allergic myocarditis].
Sukoan GV; Antelava AV; Kavadze IK; Chikobava EA; Iarovaia EV; Karsanov NV
Eksp Klin Farmakol; 2004; 67(2):19-23. PubMed ID: 15188754
[TBL] [Abstract][Full Text] [Related]
5. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
[TBL] [Abstract][Full Text] [Related]
6. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
Akki A; Seymour AM
Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action.
Day SM; Coutu P; Wang W; Herron T; Turner I; Shillingford M; Lacross NC; Converso KL; Piao L; Li J; Lopatin AN; Metzger JM
Physiol Genomics; 2008 May; 33(3):312-22. PubMed ID: 18334547
[TBL] [Abstract][Full Text] [Related]
8. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
Luptak I; Balschi JA; Xing Y; Leone TC; Kelly DP; Tian R
Circulation; 2005 Oct; 112(15):2339-46. PubMed ID: 16203912
[TBL] [Abstract][Full Text] [Related]
9. Ventricular energetics after the Fontan operation: contractility-afterload mismatch.
Szabó G; Buhmann V; Graf A; Melnitschuk S; Bährle S; Vahl CF; Hagl S
J Thorac Cardiovasc Surg; 2003 May; 125(5):1061-9. PubMed ID: 12771880
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart.
Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G
Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288
[TBL] [Abstract][Full Text] [Related]
11. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
12. Cardiac overexpression of the norepinephrine transporter uptake-1 results in marked improvement of heart failure.
Münch G; Rosport K; Bültmann A; Baumgartner C; Li Z; Laacke L; Ungerer M
Circ Res; 2005 Oct; 97(9):928-36. PubMed ID: 16166553
[TBL] [Abstract][Full Text] [Related]
13. The role of Ca2+ in coupling cardiac metabolism with regulation of contraction: in silico modeling.
Yaniv Y; Stanley WC; Saidel GM; Cabrera ME; Landesberg A
Ann N Y Acad Sci; 2008 Mar; 1123():69-78. PubMed ID: 18375579
[TBL] [Abstract][Full Text] [Related]
14. [Modifications in myocardial energy metabolism in diabetic patients]].
Grynberg A
Diabetes Metab; 2001 Nov; 27(5 Pt 2):S12-9. PubMed ID: 11910980
[TBL] [Abstract][Full Text] [Related]
15. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
Huggins CE; Domenighetti AA; Pedrazzini T; Pepe S; Delbridge LM
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):186-90. PubMed ID: 14608525
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
17. Optimizing donor heart outcome after prolonged storage with endothelial function analysis and continuous perfusion.
Poston RS; Gu J; Prastein D; Gage F; Hoffman JW; Kwon M; Azimzadeh A; Pierson RN; Griffith BP
Ann Thorac Surg; 2004 Oct; 78(4):1362-70;; discussion 1362-70. PubMed ID: 15464500
[TBL] [Abstract][Full Text] [Related]
18. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
20. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
